HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Kobo Biotech Ltd Stock Comparison

Ipca Laboratories Ltd vs Kobo Biotech Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1425 as of 09 Dec 12:23.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 51.6 on March 2025 . This represents a CAGR of 10.14% over 6 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 17538 crore on March 2020 to ₹ 38088 crore on March 2025 . This represents a CAGR of 13.80% over 6 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Ipca Laboratories Ltd for the Sep '25 is ₹ 2584 crore as compare to the Jun '25 revenue of ₹ 2341 crore. This represent the growth of 10.37% The revenue of Kobo Biotech Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Ipca Laboratories Ltd for the Sep '25 is ₹ 514.52 crore as compare to the Jun '25 ebitda of ₹ 449.08 crore. This represent the growth of 14.57% The ebitda of Kobo Biotech Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 283.5 crore over 10 quarters. This represents a CAGR of 23.81% The net profit of Kobo Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 15.59 % on March 2025 . This represents a CAGR of 8.27% over 6 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Kobo Biotech Ltd

  • Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
  • Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
  • The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories Ltd slips for fifth straight session

Ipca Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at ...

Read more

18 Dec 2025 13:35

News

Ipca Laboratories to announce Quarterly Result

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 13 Novem...

Read more

18 Oct 2025 10:40

News

Ipca Laboratories incorporates wholly owned subsidiary in Germany

Ipca Laboratories has incorporated a wholly owned subsidiary by the name 'Ipca Pharmaceuti...

Read more

16 Oct 2025 14:39

News

Ipca Laboratories Ltd eases for fifth straight session

Ipca Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at ...

Read more

14 Oct 2025 13:35

News

Ipca teams with BioSimilar Sciences PR LLC

Ipca Laboratories and BioSimilar Sciences PR LLC (BSS) today announced a definitive Techno...

Read more

24 Sep 2025 19:32

News

Ipca Labs Q1 PAT climbs 21% YoY to Rs 233 cr

Revenue from operations jumped 10.33% year on year to Rs 2,308.85 crore in the quarter end...

Read more

11 Aug 2025 14:36

Kobo Biotech Ltd News Hub

News

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 202...

Read more

13 Aug 2024 10:21

News

Kobo Biotech to convene board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 30 May 2024 P...

Read more

28 May 2024 15:31

News

Kobo Biotech to conduct board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2...

Read more

09 Feb 2024 14:57

News

Kobo Biotech to hold board meeting

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2...

Read more

03 Nov 2023 17:17

News

Kobo Biotech to hold AGM

Kobo Biotech announced that the 30th Annual General Meeting (AGM) of the company will be h...

Read more

09 Sep 2023 18:44

News

Kobo Biotech to declare Quarterly Result

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 11 August 202...

Read more

07 Aug 2023 13:02

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Kobo Biotech Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kobo Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Kobo Biotech Ltd?

Market cap of Ipca Laboratories Ltd is 35,778 Cr while Market cap of Kobo Biotech Ltd is 5 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Kobo Biotech Ltd?

The stock performance of Ipca Laboratories Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Kobo Biotech Ltd?

As of December 18, 2025, the Ipca Laboratories Ltd stock price is INR ₹1410.25. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.27.

How do dividend payouts of Ipca Laboratories Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions